Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
The American Journal of Pathology|July 12, 2011
Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphomaClaudia Günther, Nick Zimmermann, Nicole Berndt, et al.The Journal of Dermatological Treatment|April 17, 2010
Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trialMichael Meurer, Lawrence F Eichenfield, Vincent Ho, et al.Blood|July 10, 2007
G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacitySusanne H C Baumeister, Kristina Hölig, Martin Bornhäuser, et al.The Journal of Allergy and Clinical Immunology|March 8, 2011
Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responsesAnja Hänsel, Claudia Günther, Jens Ingwersen, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 24, 2009
Use of high-dose immunoglobulins in dermatologyAlexander Enk, Gerhard Fierlbeck, Lars French, et al.Dermatology (Basel, Switzerland)|June 5, 2004
Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitisMichael Meurer, Manige Fartasch, Gisela Albrecht, et al.Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 9, 2003
An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcersAnne-Kathrin Tausche, Mouna Skaria, Lorenz Böhlen, et al.Journal of the American Academy of Dermatology|May 9, 2008
A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitisThomas Schwarz, Inga Kreiselmaier, Thomas Bieber, et al.Journal of the American Academy of Dermatology|February 5, 2005
Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccinationKim A Papp, Kristine Breuer, Michael Meurer, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 15, 2012
Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune DiseasesMichael Kasperkiewicz, Rüdiger Eming, Melika Behzad, et al.Pageof 5